Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

National PPM Tuberculosis Control Project in Korea: the Korean PPM Monitoring Database between July 2019 and June 2020

Authors
Min, JinsooKim, Hyung WooKoo, Hyeon-KyoungKo, YousangOh, Jee YounKim, JaetaeYang, JiyeonKwon, YunhyungPark, Young-JoonKang, Ji YoungLee, Sung-SoonPark, Jae SeukKim, Ju Sang
Issue Date
9-11월-2020
Publisher
KOREAN ACAD MEDICAL SCIENCES
Keywords
SARS Virus; Coronavirus; Treatment Outcome; Public-private Sector Partnerships; Quality Indicators
Citation
JOURNAL OF KOREAN MEDICAL SCIENCE, v.35, no.43
Indexed
SCIE
SCOPUS
KCI
Journal Title
JOURNAL OF KOREAN MEDICAL SCIENCE
Volume
35
Number
43
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/130369
DOI
10.3346/jkms.2020.35.e388
ISSN
1011-8934
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic caused disruptions to healthcare systems and endangered the control and prevention of tuberculosis (TB). We investigated the nationwide effects of COVID-19 on the national Public-Private Mix (PPM) TB control project in Korea, using monitoring indicators from the Korean PPM monitoring database. Methods: The Korean PPM monitoring database includes data from patients registered at PPM hospitals throughout the country. Data of six monitoring indicators for active TB cases updated between July 2019 and June 2020 were collected. The data of each cohort throughout the country and in Daegu-Gyeongbuk, Seoul Metropolitan Area, and Jeonnam-Jeonbuk were collated to provide nationwide data. The data were compared using the chi(2) test for trend to evaluate quarterly trends of each monitoring indicator at the national level and in the prespecified regions. Results: Test coverages of sputum smear (P = 0.622) and culture (P = 0.815), drug susceptibility test (P = 0.750), and adherence rate to initial standard treatment (P = 0.901) at the national level were not significantly different during the study period. The rate of loss to follow-up among TB cases at the national level was not significantly different (P = 0.088); however, the treatment success rate among the smear-positive drug-susceptible pulmonary TB cohort at the national level significantly decreased, from 90.6% to 84.1% (P < 0.001). Treatment success rate in the Seoul metropolitan area also significantly decreased during the study period, from 89.4% to 84.5% (P = 0.006). Conclusion: Our study showed that initial TB management during the COVID-19 pandemic was properly administered under the PPM project in Korea. However, our study cannot confirm or conclude a decreased treatment success rate after the COVID-19 pandemic due to limited data.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE